Equities

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS:NSI

Aarey Drugs and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)67.30
  • Today's Change0.96 / 1.45%
  • Shares traded46.04k
  • 1 Year change+41.68%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue3,9564,1904,927
OPERATING EXPENSES
Cost of revenue total3,8194,0384,721
Selling, general and admin. expenses, total7.18699.75
Depreciation/amortization171620
Unusual expense(income)--0.50--
Other operating expenses, total850.0084
Total operating expense3,9294,1244,834
Operating income286693
Other, net68(2.31)26
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes5360100
Provision for income taxes6.592235
Net income after taxes473865
Minority interest------
Net income before extra. Items473865
Total extraordinary items------
Net income473865
Inc.avail. to common excl. extra. Items473865
Inc.avail. to common incl. extra. Items473865
EPS RECONCILIATION
Basic/primary weighted average shares252524
Basic/primary eps excl. extra items1.841.492.72
Basic/primary eps incl. extra items1.841.492.72
Dilution adjustment------
Diluted weighted average shares252524
Diluted eps excl. extra items1.841.492.72
Diluted eps incl. extra items1.841.492.72
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock--0--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental422116
SUPPLEMENTAL INCOME
Depreciation, supplemental171620
Total special items--0.50--
NORMALISED INCOME
Normalized income before taxes5361100
Effect of special items on income taxes--0.19--
Income tax excluding impact of special items6.592335
Normalized income after tax473865
Normalized income avail. to common473865
Basic normalized EPS1.841.502.72
Diluted normalized EPS1.841.502.72
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.